Company intelligence / Profile preview

Meril Genomics

Vapi, Gujarat, India

Ownership: Private
Development stage: Other

Overview

Meril Genomics is a molecular diagnostics innovator focused on advanced genomic testing, partnering with Vgenomics to provide non-invasive prenatal testing, targeted next-generation sequencing for tuberculosis, and whole exome sequencing for rare diseases, with a mission to expand precision medicine access in India.

Therapeutic areas: Women's HealthInfectious DiseasesRare Diseases
Modalities: Diagnostic kitGenomic test
Industry: Molecular Diagnostics

Partnerships

Vgenomics

Beyond the preview

Go deeper on Meril Genomics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Meril Genomics.

Explore the full profile